Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance

被引:56
作者
Cianflone, K
Zakarian, R
Couillard, C
Delplanque, B
Despres, JP
Sniderman, A
机构
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ H3A 1A1, Canada
[2] Univ Laval, Dept Food Sci & Nutr, Ste Foy, PQ G1K 7P4, Canada
[3] Univ Quebec, Res Ctr, Ctr Hosp, Lipid Res Ctr, Ste Foy, PQ G1V 2M3, Canada
[4] Univ Paris 11, Lab Physiol & Nutr, Orsay, France
关键词
C3adesArg; fatty acid; insulin; leptin;
D O I
10.1194/jlr.M300214-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Postprandial plasma triglyceride (ppTG) and NEFA clearance were stratified by plasma acylation-stimulating protein (ASP) and gender to determine the contribution of fasting ASP in a normal population (70 men; 71 women). In the highest ASP tertile only, ASP decreased over 8 h (90 +/- 9.7 nM to 70 +/- 5.9 nM, P < 0.05 males; 61.9 +/- 4.0 nM to 45.6 +/- 6.2 nM, P < 0.01 females). Fasting ASP correlated positively with ppTG response. ppTG (P < 0.0001, 2-way ANOVA, both genders) and NEFA levels progressively increased from lowest to highest ASP tertile, with the greatest differences in males. By stepwise multiple regression, the best prediction of ppTG was: (fasting ASP + apolipoprotein B + insulin + TG; r = 0.806) for men and (fasting ASP + total cholesterol; r = 0.574) for women. Leptin, body mass index, and other fasting variables did not improve the prediction. Thus, in men and women, ASP significantly predicted ppTG and NEFA clearance and, based on lower ASP, women may be more ASP sensitive than men. EM Plasma ASP may be useful as a fasting variable that will provide additional information regarding ppTG and NEFA clearance.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 57 条
[1]  
ASTRUP A, 1993, INT J OBESITY, V17, pS32
[2]   IMPAIRED FATTY-ACID METABOLISM IN FAMILIAL COMBINED HYPERLIPIDEMIA - A MECHANISM ASSOCIATING HEPATIC APOLIPOPROTEIN-B OVERPRODUCTION AND INSULIN-RESISTANCE [J].
CABEZAS, MC ;
DEBRUIN, TWA ;
DEVALK, HW ;
SHOULDERS, CC ;
JANSEN, H ;
ERKELENS, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :160-168
[3]   The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers [J].
Charlesworth, JA ;
Peake, PW ;
Campbell, LV ;
Pussell, BA ;
O'Grady, S ;
Tzilopoulos, T .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (11) :1096-1102
[4]   Critical review of acylation-stimulating protein physiology in humans and rodents [J].
Cianflone, K ;
Xia, ZN ;
Chen, LY .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (02) :127-143
[5]   Acylation stimulating protein (ASP), an adipocyte autocrine: new directions [J].
Cianflone, K ;
Maslowska, M ;
Sniderman, AD .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (01) :31-41
[6]   IMPAIRED RESPONSE OF FIBROBLASTS FROM PATIENTS WITH HYPERAPOBETALIPOPROTEINEMIA TO ACYLATION-STIMULATING PROTEIN [J].
CIANFLONE, KM ;
MASLOWSKA, MH ;
SNIDERMAN, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :722-730
[7]   Physiological and nutritional regulation of enzymes of triacylglycerol synthesis [J].
Coleman, RA ;
Lewin, TM ;
Muoio, DM .
ANNUAL REVIEW OF NUTRITION, 2000, 20 :77-103
[8]   Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay [J].
Contois, JH ;
LammiKeefe, CJ ;
Vogel, S ;
McNamara, JR ;
Wilson, PWF ;
Massov, T ;
Schaefer, EJ .
CLINICA CHIMICA ACTA, 1996, 253 (1-2) :21-35
[9]  
Couillard B, 1999, ARTERIOSCL THROM VAS, V19, P2448
[10]   Postprandial triglyceride response in visceral obesity in men [J].
Couillard, C ;
Bergeron, N ;
Prud'homme, D ;
Bergeron, J ;
Tremblay, A ;
Bouchard, C ;
Mauriège, P ;
Després, JP .
DIABETES, 1998, 47 (06) :953-960